Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.

Methodology: 4.5/5 Usefulness: 4/5 Stiell IG, et al. Lancet. 2020 Feb 1;395(10221):339-349 Editorial: Atrial fibrillation cardioversion in the emergency department.  Question and Methods: This partial factorial randomized trial aimed to determine which rhythm control strategy was superior; procainamide followed by electrical cardioversion if needed compared with electrical cardioversion alone. It also sought to determine whether anterolateral or antero-posterior pad placement […]

Electrical vs Chemical Cardioversion in ED patients with Atrial Fibrillation (RAFF2)

RAFF2 Ian Stiell and colleagues are back at it with atrial fibrillation; The RAFF2 trial (Electrical versus Chemical cardioversion for Emergency Department patients with Atrial Fibrillation (RAFF2); A partial factorial randomized trial) was published in The Lancet this week. Acute atrial fibrillation is an irregular dysrhythmia that should be treated within 48 hours to avoid significant complications such as stroke […]

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation

Journal Club Summary Methodology Score: 4/5 Usefulness Score: 2/5 Pluymaekers NAHA, et al. N Engl J Med. 2019 Mar 18.  Editorial: The RACE to Treat Atrial Fibrillation in the Emergency Department.  Question and Methods: This multicenter, randomized, open-label, non-inferiority trial compared delayed vs early cardioversion for emergency department patients with recent-onset, symptomatic atrial fibrillation. Findings: Sinus rhythm at four weeks […]